Top Midday Decliners

MT Newswires Live
28 Dec 2024

180 Life Sciences (ATNF) priced a $2.9 million at-the-market direct offering of stock and warrants and a concurrent private placement, the biotechnology company said on Friday. 180 Life Science issued 1.2 million shares priced at $2.41 apiece along an equal number of warrants exercisable anytime over the next 66 months at $2.28 per share.

180 Life Sciences recently were down by 21%, recovering modestly from a 27% decline earlier in Friday's session. Around 392,000 shares have traded so far on Friday compared with a daily average of more than 2.3 million shares.

Brookfield Asset Management (BAM) and co-investors reportedly have purchased a 53% stake in French renewables developer Neoen, paying 39.85 euros ($41.53) per share. Brookfield and its partners now expect to begin a tender offer to acquire the remaining shares in Neoen, according to a Bloomberg report on Friday.

Brookfield Asset Management shares recently were down by nearly 2%, staying close to their intra-day low of $54.17 apiece. Trading volume was light, with around 200,000 shares exchanged compared with a daily average of over 992,000 shares per day.

KeyCorp (KEY) said on Friday that Bank of Nova Scotia (BNS, BNS.TO) now owns about 15% of the bank's common stock following a $2 billion stock sale with the Canadian banking company.

KeyCorp shares recently were down about 1%. Investors have exchanged more than 2.3 million Keycorp shares compared with an average of 9.4 million shares daily.

Price: 2.24, Change: -0.59, Percent Change: -20.85

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10